pubmed-article:18381950 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0473169 | lld:lifeskim |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0850639 | lld:lifeskim |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0538927 | lld:lifeskim |
pubmed-article:18381950 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:18381950 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:18381950 | pubmed:dateCreated | 2008-4-2 | lld:pubmed |
pubmed-article:18381950 | pubmed:abstractText | Cyclooxygenase-2 (COX-2)-specific inhibition suppresses carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer. In this pilot randomized phase II study, we evaluated the efficacy and safety of the COX-2 inhibitor celecoxib in patients with oral premalignant lesions (OPL). | lld:pubmed |
pubmed-article:18381950 | pubmed:language | eng | lld:pubmed |
pubmed-article:18381950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18381950 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18381950 | pubmed:month | Apr | lld:pubmed |
pubmed-article:18381950 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:DeysSS | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:DannenbergAnd... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:LeeJ JackJJ | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:LippmanScott... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:HelmanJoseph... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:BoyleJay OJO | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:NathanCherie-... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:El-NaggarAdel... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:YuehBevanB | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:Papadimitrako... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:DuBaohengB | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:PetersonDougl... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:OndreyFrank... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:WilliamWillia... | lld:pubmed |
pubmed-article:18381950 | pubmed:author | pubmed-author:AtwellAntheaA | lld:pubmed |
pubmed-article:18381950 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18381950 | pubmed:day | 1 | lld:pubmed |
pubmed-article:18381950 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:18381950 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18381950 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18381950 | pubmed:pagination | 2095-101 | lld:pubmed |
pubmed-article:18381950 | pubmed:dateRevised | 2009-10-28 | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:meshHeading | pubmed-meshheading:18381950... | lld:pubmed |
pubmed-article:18381950 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18381950 | pubmed:articleTitle | Pilot randomized phase II study of celecoxib in oral premalignant lesions. | lld:pubmed |
pubmed-article:18381950 | pubmed:affiliation | Department of Thoracic/Head, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. vpapadim@mdanderson.org | lld:pubmed |
pubmed-article:18381950 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18381950 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:18381950 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18381950 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:18381950 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381950 | lld:pubmed |